Intravenous Levetiracetam in Children With Seizures: A Prospective Safety Study
Department
neurology
Document Type
Article
Abstract
In 2006, intravenous levetiracetam received US Food and Drug Administration (FDA) approval for adjunctive treatment of partial onset seizures in adults with epilepsy, 16 years or older. We have established the safety, tolerability, and dosage of intravenous levetiracetam in children. This prospective study included 30 children (6 months to
Medical Subject Headings
neurology
Publication Date
2010
Publication Title
Journal of Child Neurology
ISSN
0883-0738
Volume
25
Issue
5
First Page
551
Last Page
555
Digital Object Identifier (DOI)
10.1177/0883073809348795
Recommended Citation
Ng, Yu Tze; Hastriter, V.; Cardenas, Javier F.; Khoury, Emily M.; and Chapman, Kevin E., "Intravenous Levetiracetam in Children With Seizures: A Prospective Safety Study" (2010). Neurology. 38.
https://scholar.barrowneuro.org/neurology/38
COinS